We can make biofuels with algae, but can we make them commercially viable? IMB is working towards it – and Siemens, Neste Oil Corp, the Queensland Government and others have joined their quest.
Prototypes of a portable test for Zika virus and a range of other diseases, using just a microchip plugged into a smartphone, may be available soon. The new test could be performed from the comfort of the patient’s own home according to IMB's Professor Kirill Alexandrov.
An international team involving University of Queensland researchers has used advanced genome sequencing to diagnose 30 patients with unresolved rare diseases.
UQ’s Community for Open Antimicrobial Drug Discovery (CO-ADD) has signed a Memorandum of Understanding (MOU) with the African Network for Drugs and Diagnostics Innovation (ANDI) which is hosted by the United Nations Office for Project Services (UNOPS).
Researchers from The University of Queensland (UQ) are advancing their mission to discover new antibiotics capable of combating multi-drug resistant bacterial infections after signing an agreement to screen the entire French National Chemical Library.
The Community for Open Antimicrobial Drug Discovery (CO-ADD) at The University of Queensland’s Institute for Molecular Bioscience (IMB) and the Innovative Medicines Initiative (IMI) ENABLE project have aligned to develop potential new antibiotics against multi-drug resistant bacterial infections.
A drug development project that combines the expertise of Pfizer and Institute for Molecular Bioscience researchers has been recognised at a University of Queensland awards ceremony.
